Query psy2989
Match_columns 66
No_of_seqs 61 out of 63
Neff 4.7
Searched_HMMs 29240
Date Fri Aug 16 22:39:44 2013
Command hhsearch -i /work/01045/syshi/Psyhhblits/psy2989.a3m -d /work/01045/syshi/HHdatabase/pdb70.hhm -o /work/01045/syshi/hhsearch_pdb/2989hhsearch_pdb -cpu 12 -v 0
No Hit Prob E-value P-value Score SS Cols Query HMM Template HMM
1 3uon_A Human M2 muscarinic ace 97.3 0.0007 2.4E-08 46.5 6.5 58 2-66 64-121 (467)
2 3pbl_A D(3) dopamine receptor, 97.2 0.0013 4.4E-08 45.5 6.9 59 2-66 79-137 (481)
3 3rze_A Histamine H1 receptor, 97.2 0.0012 4E-08 45.2 6.6 58 2-66 49-106 (452)
4 4amj_A Beta-1 adrenergic recep 97.2 0.00095 3.2E-08 43.1 5.7 58 2-66 52-109 (315)
5 4grv_A Neurotensin receptor ty 97.1 0.0015 5.1E-08 47.0 6.6 60 2-66 76-135 (510)
6 3sn6_R Lysozyme, beta-2 adrene 97.0 0.0016 5.4E-08 46.5 6.1 58 2-66 223-280 (514)
7 4dkl_A MU-type opioid receptor 97.0 0.0022 7.4E-08 43.9 6.3 57 2-66 58-114 (464)
8 2ks9_A Substance-P receptor; w 96.9 0.0027 9.4E-08 42.4 6.6 58 2-66 73-130 (364)
9 2rh1_A Beta-2-adrenergic recep 96.9 0.0026 9E-08 45.3 6.7 58 2-66 81-138 (500)
10 1u19_A Rhodopsin; G protein-co 96.9 0.0033 1.1E-07 41.4 6.7 58 2-66 79-136 (349)
11 2z73_A Rhodopsin; visual pigme 96.8 0.0033 1.1E-07 43.6 6.4 58 2-66 75-133 (448)
12 3eml_A Human adenosine A2A rec 96.7 0.0029 1E-07 43.5 5.3 56 2-66 62-117 (488)
13 4eiy_A Adenosine receptor A2A/ 96.5 0.0052 1.8E-07 41.9 5.6 56 2-66 72-127 (447)
14 3vw7_A Proteinase-activated re 96.4 0.0091 3.1E-07 41.2 6.5 58 2-66 61-118 (484)
15 4ea3_A Fusion protein of nocic 96.4 0.011 3.7E-07 41.2 6.5 57 2-66 166-222 (434)
16 3odu_A C-X-C chemokine recepto 95.8 0.031 1E-06 38.7 6.6 56 2-66 89-144 (502)
17 3v2y_A Sphingosine 1-phosphate 95.1 0.048 1.6E-06 39.1 5.9 57 2-66 104-160 (520)
18 2lnl_A C-X-C chemokine recepto 93.6 0.21 7.3E-06 32.4 6.0 56 2-66 52-107 (296)
No 1
>3uon_A Human M2 muscarinic acetylcholine, receptor T4 LY fusion protein; G protein-coupled receptor, GPCR, SI protein-antagonist complex; HET: QNB BGC; 3.00A {Homo sapiens} PDB: 4daj_A*
Probab=97.30 E-value=0.0007 Score=46.51 Aligned_cols=58 Identities=17% Similarity=0.264 Sum_probs=44.7
Q ss_pred chhhHhhhhhhhhhhHHHHHHhhcCCCCCCchhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcC
Q psy2989 2 AMALSDMFTLLFPAPWLFYMYTFGNHYKPLSPVAACYAWNIMNEVIPTLFHTASIWLTLALAVQR 66 (66)
Q Consensus 2 ~mAvaDllvml~y~P~~~y~y~~~~~~~~~~p~~~~y~~~~~h~~~~~~~HTiSiwLTv~LAv~R 66 (66)
+||+||+++++..+|+.+..+..++.. .....|... ..+..++...|+|..+++|+-|
T Consensus 64 ~La~aDll~~~~~~p~~~~~~~~~~~~---~~~~~C~~~----~~~~~~~~~~s~~~l~~isidR 121 (467)
T 3uon_A 64 SLACADLIIGVFSMNLYTLYTVIGYWP---LGPVVCDLW----LALDYVVSNASVMNLLIISFDR 121 (467)
T ss_dssp HHHHHHHHHHHTHHHHHHHHHHSSSCC---SCHHHHHHH----HHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHHhcCCcc---CCcchHhHH----HHHHHHHHHHHHHHHHHHHHHH
Confidence 699999999999999998887754322 334556544 4567788899999999999866
No 2
>3pbl_A D(3) dopamine receptor, lysozyme chimera; structural genomics, PSI-2, PSI-biology, protein structure initiative; HET: ETQ MAL; 2.89A {Homo sapiens}
Probab=97.19 E-value=0.0013 Score=45.46 Aligned_cols=59 Identities=24% Similarity=0.547 Sum_probs=43.7
Q ss_pred chhhHhhhhhhhhhhHHHHHHhhcCCCCCCchhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcC
Q psy2989 2 AMALSDMFTLLFPAPWLFYMYTFGNHYKPLSPVAACYAWNIMNEVIPTLFHTASIWLTLALAVQR 66 (66)
Q Consensus 2 ~mAvaDllvml~y~P~~~y~y~~~~~~~~~~p~~~~y~~~~~h~~~~~~~HTiSiwLTv~LAv~R 66 (66)
+||+||+++++..+|+.++....++.. ......|... ..+..++...|+|..+++|+-|
T Consensus 79 ~La~aDll~~~~~~p~~~~~~~~~~~~--~~~~~~C~~~----~~~~~~~~~~s~~~l~~is~dR 137 (481)
T 3pbl_A 79 SLAVADLLVATLVMPWVVYLEVTGGVW--NFSRICCDVF----VTLDVMMCTASIWNLCAISIDR 137 (481)
T ss_dssp HHHHHHHHHHHHTHHHHHHHHHTTSCC--CSCHHHHHHH----HHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHHHhcCcc--ccCcchhhhH----HHHHHHHHHHHHHHHHHHHHHH
Confidence 699999999999999998877653322 1224455444 3466778899999999999865
No 3
>3rze_A Histamine H1 receptor, lysozyme chimera; structural genomics, PSI-biology, membrane protein, GPCR NET GPCR, hydrolase; HET: 5EH D7V OLC; 3.10A {Homo sapiens}
Probab=97.17 E-value=0.0012 Score=45.18 Aligned_cols=58 Identities=17% Similarity=0.292 Sum_probs=44.1
Q ss_pred chhhHhhhhhhhhhhHHHHHHhhcCCCCCCchhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcC
Q psy2989 2 AMALSDMFTLLFPAPWLFYMYTFGNHYKPLSPVAACYAWNIMNEVIPTLFHTASIWLTLALAVQR 66 (66)
Q Consensus 2 ~mAvaDllvml~y~P~~~y~y~~~~~~~~~~p~~~~y~~~~~h~~~~~~~HTiSiwLTv~LAv~R 66 (66)
+||+||+++++..+|+.+..+..++. ......|... ..+...+...|+|..+++|+-|
T Consensus 49 ~La~~Dll~~~~~~p~~~~~~~~~~~---~~~~~~C~~~----~~~~~~~~~~s~~~l~~is~dR 106 (452)
T 3rze_A 49 SLSVADLIVGAVVMPMNILYLLMSKW---SLGRPLCLFW----LSMDYVASTASIFSVFILCIDR 106 (452)
T ss_dssp HHHHHHHHHHHTHHHHHHHHHHSSSC---SSHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHHHcCCc---cCCchhHhHH----HHHHHHHHHHHHHHHHHHHHHH
Confidence 69999999999999999988775432 2334455444 4466778899999999999865
No 4
>4amj_A Beta-1 adrenergic receptor; membrane protein, 7TMR BETA1-adrenoceptor, stabilising mutat biased agonist; HET: CVD 2CV; 2.30A {Meleagris gallopavo} PDB: 2y01_A* 2y02_A* 2y03_A* 2y04_A* 4ami_A* 2y00_A* 2vt4_A* 2ycw_A* 2ycx_A* 2ycy_A* 2ycz_A*
Probab=97.16 E-value=0.00095 Score=43.12 Aligned_cols=58 Identities=24% Similarity=0.301 Sum_probs=43.7
Q ss_pred chhhHhhhhhhhhhhHHHHHHhhcCCCCCCchhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcC
Q psy2989 2 AMALSDMFTLLFPAPWLFYMYTFGNHYKPLSPVAACYAWNIMNEVIPTLFHTASIWLTLALAVQR 66 (66)
Q Consensus 2 ~mAvaDllvml~y~P~~~y~y~~~~~~~~~~p~~~~y~~~~~h~~~~~~~HTiSiwLTv~LAv~R 66 (66)
+||+||+++++..+|+.+.....++.. .....|..+ ..+...+...|+|..+.+|+-|
T Consensus 52 ~LaiaDll~~~~~~p~~~~~~~~~~~~---~~~~~C~~~----~~~~~~~~~~S~~~l~~isidR 109 (315)
T 4amj_A 52 SLACADLVVGLLVVPFGATLVVRGTWL---WGSFLCELW----TSLDVLCVTASIETLCVIAIDR 109 (315)
T ss_dssp HHHHHHHHCCCCCHHHHHHHHHHSSCC---SCHHHHHHH----HHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhccHHHHHHhcCCee---ccccHHHHH----HHHHHHHHHHHHHHHHHHHHHH
Confidence 699999999999999988877654322 334456544 4466777889999999999866
No 5
>4grv_A Neurotensin receptor type 1, lysozyme chimera; G-protein coupled receptor, G-protein, signaling protein-agonist complex; HET: EPE; 2.80A {Rattus norvegicus}
Probab=97.07 E-value=0.0015 Score=47.03 Aligned_cols=60 Identities=25% Similarity=0.339 Sum_probs=43.6
Q ss_pred chhhHhhhhhhhhhhHHHHHHhhcCCCCCCchhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcC
Q psy2989 2 AMALSDMFTLLFPAPWLFYMYTFGNHYKPLSPVAACYAWNIMNEVIPTLFHTASIWLTLALAVQR 66 (66)
Q Consensus 2 ~mAvaDllvml~y~P~~~y~y~~~~~~~~~~p~~~~y~~~~~h~~~~~~~HTiSiwLTv~LAv~R 66 (66)
+||+||+++.+..+|+.++.+...+.. -......|..+ ..+..++-++|++..+++|+-|
T Consensus 76 ~La~aDll~~~~~~p~~~~~~~~~~~~-w~~g~~~C~~~----~~~~~~~~~~S~~~l~~is~dR 135 (510)
T 4grv_A 76 SLALSDLLILLLAMPVELYNFIWVHHP-WAFGDAGCRGY----YFLRDACTYATALNVASLSVAR 135 (510)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTTCCSS-CSSHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHhCCC-EEhhHHHHHHH----HHHHHHHHHHHHHHHHHHHHHh
Confidence 699999999999999998877643321 12224455444 3466678899999999998865
No 6
>3sn6_R Lysozyme, beta-2 adrenergic receptor; seven transmembrane receptor, nanobody, G protein-coupled RE GPCR, signal transduction, G protein signaling; HET: P0G; 3.20A {Enterobacteria phage T4} PDB: 3kj6_A 2r4s_A 2r4r_A 4gbr_A*
Probab=97.00 E-value=0.0016 Score=46.50 Aligned_cols=58 Identities=26% Similarity=0.178 Sum_probs=44.1
Q ss_pred chhhHhhhhhhhhhhHHHHHHhhcCCCCCCchhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcC
Q psy2989 2 AMALSDMFTLLFPAPWLFYMYTFGNHYKPLSPVAACYAWNIMNEVIPTLFHTASIWLTLALAVQR 66 (66)
Q Consensus 2 ~mAvaDllvml~y~P~~~y~y~~~~~~~~~~p~~~~y~~~~~h~~~~~~~HTiSiwLTv~LAv~R 66 (66)
+||+||+++++..+|+.+.....++.. .....|..+ ..+...+.++|+|..+++|+-|
T Consensus 223 nLAiaDll~~~~~~p~~~~~~~~~~~~---~~~~~C~~~----~~l~~~~~~~S~~~l~~isidR 280 (514)
T 3sn6_R 223 SLACADLVMGLAVVPFGAAHILTKTWT---FGNFWCEFW----TSIDVLCVTASIETLCVIAVDR 280 (514)
T ss_dssp HHHHHHHTTTTTHHHHHHHHHHHTSCC---SCSHHHHHH----HHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhCHHHHHHHHcCCee---CCcchhhhH----HHHHHHHHHHHHHHHHHHHHHH
Confidence 699999999999999998877754322 224455444 4466678899999999999876
No 7
>4dkl_A MU-type opioid receptor, lysozyme chimera; G-protein coupled receptor, 7 transmembrane receptor, signal protein-antagonist complex; HET: BF0 CLR MPG 1PE; 2.80A {Mus musculus} PDB: 4ej4_A* 4djh_A*
Probab=96.97 E-value=0.0022 Score=43.87 Aligned_cols=57 Identities=21% Similarity=0.194 Sum_probs=42.4
Q ss_pred chhhHhhhhhhhhhhHHHHHHhhcCCCCCCchhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcC
Q psy2989 2 AMALSDMFTLLFPAPWLFYMYTFGNHYKPLSPVAACYAWNIMNEVIPTLFHTASIWLTLALAVQR 66 (66)
Q Consensus 2 ~mAvaDllvml~y~P~~~y~y~~~~~~~~~~p~~~~y~~~~~h~~~~~~~HTiSiwLTv~LAv~R 66 (66)
+||+||+++++. +|+.+..+..++.. .....|..+ ..+..++..+|+|..+++|+-|
T Consensus 58 ~La~~Dll~~~~-~p~~~~~~~~~~~~---~~~~~C~~~----~~~~~~~~~~s~~~l~~is~dR 114 (464)
T 4dkl_A 58 NLALADALATST-LPFQSVNYLMGTWP---FGNILCKIV----ISIDYYNMFTSIFTLCTMSVDR 114 (464)
T ss_dssp HHHHHHHHHHHH-HHHHHHHHHHSSCC---SCSHHHHHH----HHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHH-HHHHHHHHHhCCcc---cccchhhhH----HHHHHHHHHHHHHHHHHHHHHH
Confidence 699999999988 99888777755422 234456444 4466778889999999999865
No 8
>2ks9_A Substance-P receptor; water, autodock, NK1, neuropeptide receptor-NEU complex; NMR {Homo sapiens} PDB: 2ksa_A 2ksb_A
Probab=96.94 E-value=0.0027 Score=42.36 Aligned_cols=58 Identities=21% Similarity=0.213 Sum_probs=42.9
Q ss_pred chhhHhhhhhhhhhhHHHHHHhhcCCCCCCchhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcC
Q psy2989 2 AMALSDMFTLLFPAPWLFYMYTFGNHYKPLSPVAACYAWNIMNEVIPTLFHTASIWLTLALAVQR 66 (66)
Q Consensus 2 ~mAvaDllvml~y~P~~~y~y~~~~~~~~~~p~~~~y~~~~~h~~~~~~~HTiSiwLTv~LAv~R 66 (66)
+||+||+++++..+|+.+.....++.. .....|... ..+...+...|+|..+.+|+-|
T Consensus 73 ~LaiaDll~~~~~~p~~~~~~~~~~~~---~~~~~C~~~----~~~~~~~~~~s~~~l~~isidR 130 (364)
T 2ks9_A 73 NLAFAEASMAAFNTVVNFTYAVHNEWY---YGLFYCKFH----NFFPIAAVFASIYSMTAVAFDR 130 (364)
T ss_dssp HHHHHHHHHHHTHHHHHHHHHHHTSCS---SCHHHHHHH----HHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHHHcCCcc---chHHHHHhH----HHHHHHHHHHHHHHHHHHHHHH
Confidence 699999999999999987766543321 234456443 4566778889999999999866
No 9
>2rh1_A Beta-2-adrenergic receptor/T4-lysozyme chimera; GPCR, 7TM, fusion, lipidic cubic phase, lipidic, mesophase, cholesterol, membrane protein; HET: MAL CAU CLR PLM 12P; 2.40A {Homo sapiens} PDB: 3p0g_A* 3d4s_A* 3ny8_A* 3ny9_A* 3nya_A* 3pds_A*
Probab=96.92 E-value=0.0026 Score=45.30 Aligned_cols=58 Identities=26% Similarity=0.184 Sum_probs=42.7
Q ss_pred chhhHhhhhhhhhhhHHHHHHhhcCCCCCCchhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcC
Q psy2989 2 AMALSDMFTLLFPAPWLFYMYTFGNHYKPLSPVAACYAWNIMNEVIPTLFHTASIWLTLALAVQR 66 (66)
Q Consensus 2 ~mAvaDllvml~y~P~~~y~y~~~~~~~~~~p~~~~y~~~~~h~~~~~~~HTiSiwLTv~LAv~R 66 (66)
+||+||+++++..+|+.+..+..+... .....|..+ ..+..++..+|+|..+++|+-|
T Consensus 81 nLAiaDll~~~~~~p~~~~~~~~~~w~---~~~~~C~~~----~~~~~~~~~~Si~~l~~isidR 138 (500)
T 2rh1_A 81 SLACADLVMGLAVVPFGAAHILMKMWT---FGNFWCEFW----TSIDVLCVTASIETLCVIAVDR 138 (500)
T ss_dssp HHHHHHHHHHHHTHHHHHHHHHHTSCC---SHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHHHhCCCc---CCcchhhHH----HHHHHHHHHHHHHHHHHHHHHH
Confidence 699999999999999988877654321 334456444 3455667789999999999865
No 10
>1u19_A Rhodopsin; G protein-coupled receptor, membrane protein, retinal protei photoreceptor, signaling protein; HET: MAN NAG BMA RET PLM HTO HTG; 2.20A {Bos taurus} SCOP: f.13.1.2 PDB: 1hzx_A* 1gzm_A* 1l9h_A* 2g87_A* 2hpy_A* 2i35_A* 2i36_A* 2i37_A* 2ped_A* 3oax_A* 3c9l_A* 1jfp_A* 1ln6_A* 1f88_A* 3cap_A* 3dqb_A* 3pqr_A* 3pxo_A* 3c9m_A* 2x72_A* ...
Probab=96.92 E-value=0.0033 Score=41.40 Aligned_cols=58 Identities=21% Similarity=0.354 Sum_probs=42.8
Q ss_pred chhhHhhhhhhhhhhHHHHHHhhcCCCCCCchhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcC
Q psy2989 2 AMALSDMFTLLFPAPWLFYMYTFGNHYKPLSPVAACYAWNIMNEVIPTLFHTASIWLTLALAVQR 66 (66)
Q Consensus 2 ~mAvaDllvml~y~P~~~y~y~~~~~~~~~~p~~~~y~~~~~h~~~~~~~HTiSiwLTv~LAv~R 66 (66)
+||+||+++++..+|..++....+.. ......|.. ...+...+...|+|..+.+|+-|
T Consensus 79 ~Lai~Dll~~~~~~~~~~~~~~~~~~---~~~~~~C~~----~~~~~~~~~~~s~~~l~~isidR 136 (349)
T 1u19_A 79 NLAVADLFMVFGGFTTTLYTSLHGYF---VFGPTGCNL----EGFFATLGGEIALWSLVVLAIER 136 (349)
T ss_dssp HHHHHHHHHHHHTHHHHHHHHHHTSC---TTHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhcchHHHHHHhcCee---eCChhHHHH----HHHHHHHHHHHHHHHHHHHHHHH
Confidence 69999999999999998877664331 123444543 34556678889999999999866
No 11
>2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A*
Probab=96.83 E-value=0.0033 Score=43.60 Aligned_cols=58 Identities=22% Similarity=0.260 Sum_probs=41.6
Q ss_pred chhhHhhhhhhhh-hhHHHHHHhhcCCCCCCchhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcC
Q psy2989 2 AMALSDMFTLLFP-APWLFYMYTFGNHYKPLSPVAACYAWNIMNEVIPTLFHTASIWLTLALAVQR 66 (66)
Q Consensus 2 ~mAvaDllvml~y-~P~~~y~y~~~~~~~~~~p~~~~y~~~~~h~~~~~~~HTiSiwLTv~LAv~R 66 (66)
+||+||+++++.. +|+.+.....++. ......|.. ...+...+.+.|+|+.+++|+-|
T Consensus 75 ~LaiaDll~~~~~~~p~~~~~~~~~~~---~~~~~~C~~----~~~~~~~~~~~S~~~l~~isidR 133 (448)
T 2z73_A 75 NLAFSDFTFSLVNGFPLMTISCFLKKW---IFGFAACKV----YGFIGGIFGFMSIMTMAMISIDR 133 (448)
T ss_dssp HHHHHHHHHHHHHSTTHHHHHHHTTSC---CSHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhccHHHHHHhcCCc---cCCHHHHHH----HHHHHHHHHHHHHHHHHHHHHHH
Confidence 6999999999875 8887766553321 122444543 34566788899999999999876
No 12
>3eml_A Human adenosine A2A receptor/T4 lysozyme chimera; caffeine, GPCR, membrane protein, LCP, mesophase, structural genomics, PSI-2; HET: ZMA STE; 2.60A {Homo sapiens} PDB: 3qak_A*
Probab=96.70 E-value=0.0029 Score=43.49 Aligned_cols=56 Identities=21% Similarity=0.383 Sum_probs=41.2
Q ss_pred chhhHhhhhhhhhhhHHHHHHhhcCCCCCCchhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcC
Q psy2989 2 AMALSDMFTLLFPAPWLFYMYTFGNHYKPLSPVAACYAWNIMNEVIPTLFHTASIWLTLALAVQR 66 (66)
Q Consensus 2 ~mAvaDllvml~y~P~~~y~y~~~~~~~~~~p~~~~y~~~~~h~~~~~~~HTiSiwLTv~LAv~R 66 (66)
+||+||+++++..+|+.+..+. + .......|. +...+..++..+|+|..+++|+-|
T Consensus 62 ~La~aDll~~~~~~p~~~~~~~-~----~~~~~~~C~----~~~~~~~~~~~~s~~~l~~is~dR 117 (488)
T 3eml_A 62 SLAAADIAVGVLAIPFAITIST-G----FCAACHGCL----FIACFVLVLTQSSIFSLLAIAIDR 117 (488)
T ss_dssp HHHHHHHHHHHTHHHHHHHHTT-C----CEECHHHHH----HHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHhc-c----ccccchHHH----HHHHHHHHHHHHHHHHHHHHHHHh
Confidence 6999999999999999887554 1 112234454 344566778889999999999865
No 13
>4eiy_A Adenosine receptor A2A/soluble cytochrome B562 CH; novel protein engineering, GPCR network, PSI-biology, struct genomics, membrane protein, GPCR; HET: ZMA CLR OLA OLC OLB; 1.80A {Homo sapiens} PDB: 3vg9_A* 3vga_A* 2ydv_A* 2ydo_A* 3uza_A* 3rey_A* 3rfm_A* 3pwh_A* 3uzc_A* 4er9_A
Probab=96.52 E-value=0.0052 Score=41.88 Aligned_cols=56 Identities=20% Similarity=0.287 Sum_probs=40.3
Q ss_pred chhhHhhhhhhhhhhHHHHHHhhcCCCCCCchhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcC
Q psy2989 2 AMALSDMFTLLFPAPWLFYMYTFGNHYKPLSPVAACYAWNIMNEVIPTLFHTASIWLTLALAVQR 66 (66)
Q Consensus 2 ~mAvaDllvml~y~P~~~y~y~~~~~~~~~~p~~~~y~~~~~h~~~~~~~HTiSiwLTv~LAv~R 66 (66)
+||+||+++++..+|+.+..+... ......|... ..+...+...|+|..+.+|+-|
T Consensus 72 ~La~~Dll~~~~~~p~~~~~~~~~-----~~~~~~C~~~----~~~~~~~~~~S~~~l~~is~dR 127 (447)
T 4eiy_A 72 SLAAADIAVGVLAIPFAITISTGF-----CAACHGCLFI----ACFVLVLTQSSIFSLLAIAIDR 127 (447)
T ss_dssp HHHHHHHHHHHTHHHHHHHHHTTC-----EEEHHHHHHH----HHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHhccc-----ccCccHHHHH----HHHHHHHHHHHHHHHHHHHHHH
Confidence 699999999999999988754411 1223345433 4556677889999999999865
No 14
>3vw7_A Proteinase-activated receptor 1, lysozyme; high resolution structure, protease-activated receptor 1, in conformation, antagonist vorapaxar; HET: VPX OLC; 2.20A {Homo sapiens}
Probab=96.44 E-value=0.0091 Score=41.20 Aligned_cols=58 Identities=19% Similarity=0.213 Sum_probs=38.8
Q ss_pred chhhHhhhhhhhhhhHHHHHHhhcCCCCCCchhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcC
Q psy2989 2 AMALSDMFTLLFPAPWLFYMYTFGNHYKPLSPVAACYAWNIMNEVIPTLFHTASIWLTLALAVQR 66 (66)
Q Consensus 2 ~mAvaDllvml~y~P~~~y~y~~~~~~~~~~p~~~~y~~~~~h~~~~~~~HTiSiwLTv~LAv~R 66 (66)
+||+||+++++. +|+....+..++.. ......|..+ ..+..++-.+|+|..+++|+-|
T Consensus 61 ~La~aDll~~~~-~~~~~~~~~~~~~~--~~~~~~C~~~----~~~~~~~~~~S~~~l~~is~dR 118 (484)
T 3vw7_A 61 HLATADVLFVSV-LPFKISYYFSGSDW--QFGSELCRFV----TAAFYCNMYASILLMTVISIDR 118 (484)
T ss_dssp HHHHHHHHHHTT-HHHHHHHHHTTSCC--CSCHHHHHHH----HHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHH-HHHHHHHHHhcCCc--ccchhHHhHH----HHHHHHHHHHHHHHHHHHHHHH
Confidence 699999999876 55555555433212 2334556544 3456677789999999999865
No 15
>4ea3_A Fusion protein of nociceptin receptor and cytochr; PSI-biology GPCR network, structural genomics, GPCR membrane 7TM NOP ORL1 cytochrome B562; HET: 0NN OLB OLA OLC; 3.01A {Homo sapiens}
Probab=96.37 E-value=0.011 Score=41.16 Aligned_cols=57 Identities=23% Similarity=0.186 Sum_probs=41.4
Q ss_pred chhhHhhhhhhhhhhHHHHHHhhcCCCCCCchhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcC
Q psy2989 2 AMALSDMFTLLFPAPWLFYMYTFGNHYKPLSPVAACYAWNIMNEVIPTLFHTASIWLTLALAVQR 66 (66)
Q Consensus 2 ~mAvaDllvml~y~P~~~y~y~~~~~~~~~~p~~~~y~~~~~h~~~~~~~HTiSiwLTv~LAv~R 66 (66)
+||+||+++ +..+|+.+..+..++.. .....|..+ ..+...+...|+|..+.+|+-|
T Consensus 166 ~LAvsDll~-~~~~p~~~~~~~~~~~~---~~~~~C~~~----~~~~~~~~~~S~~~l~~isidR 222 (434)
T 4ea3_A 166 NLALADTLV-LLTLPFQGTDILLGFWP---FGNALCKTV----IAIDYYNMFTSTFTLTAMSVDR 222 (434)
T ss_dssp HHHHHHHHH-HTTHHHHHHHHHHTSCT---THHHHHHHH----HHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHH-HHHhHHHHHHHHhcCCc---CcccHHHHH----HHHHHHHHHHHHHHHHHHHHHH
Confidence 699999998 67789888777755421 334445444 4556778889999999999876
No 16
>3odu_A C-X-C chemokine receptor type 4, lysozyme chimera; structural genomics, PSI-2, protein structure initiative; HET: ITD OLC OLA; 2.50A {Homo sapiens} PDB: 3oe8_A* 3oe6_A* 3oe0_A* 3oe9_A* 2k03_B* 2k04_B 2k05_B*
Probab=95.81 E-value=0.031 Score=38.73 Aligned_cols=56 Identities=20% Similarity=0.266 Sum_probs=39.9
Q ss_pred chhhHhhhhhhhhhhHHHHHHhhcCCCCCCchhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcC
Q psy2989 2 AMALSDMFTLLFPAPWLFYMYTFGNHYKPLSPVAACYAWNIMNEVIPTLFHTASIWLTLALAVQR 66 (66)
Q Consensus 2 ~mAvaDllvml~y~P~~~y~y~~~~~~~~~~p~~~~y~~~~~h~~~~~~~HTiSiwLTv~LAv~R 66 (66)
+||+||+++. ..+|+.+..+.. + .......|... ..+..++...|+|..+++|+-|
T Consensus 89 ~La~~Dll~~-~~~p~~~~~~~~-~---~~~~~~~C~~~----~~~~~~~~~~s~~~l~~is~dR 144 (502)
T 3odu_A 89 HLSVADLLFV-ITLPFWAVDAVA-N---WYFGNFLCKAV----HVIYTVNLYSSVWILAFISLDR 144 (502)
T ss_dssp HHHHHHHHHH-TTHHHHHHHHHT-C---CCSHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHH-HHHHHHHHHHhc-C---CcCCchhhhhH----HHHHHHHHHHHHHHHHHHHHHH
Confidence 6999999995 688988776653 2 11233445444 4566778889999999999865
No 17
>3v2y_A Sphingosine 1-phosphate receptor 1, lysozyme CHIM; EDG receptor, lipid receptor, multiple sclerosi autoimmunity, structural genomics, PSI-biology; HET: ML5 NAG; 2.80A {Homo sapiens} PDB: 3v2w_A*
Probab=95.13 E-value=0.048 Score=39.13 Aligned_cols=57 Identities=23% Similarity=0.203 Sum_probs=38.9
Q ss_pred chhhHhhhhhhhhhhHHHHHHhhcCCCCCCchhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcC
Q psy2989 2 AMALSDMFTLLFPAPWLFYMYTFGNHYKPLSPVAACYAWNIMNEVIPTLFHTASIWLTLALAVQR 66 (66)
Q Consensus 2 ~mAvaDllvml~y~P~~~y~y~~~~~~~~~~p~~~~y~~~~~h~~~~~~~HTiSiwLTv~LAv~R 66 (66)
+||+||+++++..+|..+.... .... .....|. +...+..++-.+|++..+++|+-|
T Consensus 104 nLA~aDll~~~~~~p~~~~~~~-~~~~---~~~~~c~----~~~~~~~~~~~~S~~~l~~isidR 160 (520)
T 3v2y_A 104 NLALSDLLAGVAYTANLLLSGA-TTYK---LTPAQWF----LREGSMFVALSASVFSLLAIAIER 160 (520)
T ss_dssp HHHHHHHHHHHHHHHHHHHSGG-GGTT---SCHHHHH----HHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHccc-ccee---eCccccc----hHHHHHHHHHHHHHHHHHHHHHHH
Confidence 6999999999999998876522 1111 2233343 334456677789999999988866
No 18
>2lnl_A C-X-C chemokine receptor type 1; G protein coupled receptor, GPCR, membrane protei transmembrane, 7TM, phospholipid, signaling, signaling PROT; NMR {Homo sapiens}
Probab=93.60 E-value=0.21 Score=32.38 Aligned_cols=56 Identities=18% Similarity=0.200 Sum_probs=33.5
Q ss_pred chhhHhhhhhhhhhhHHHHHHhhcCCCCCCchhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcC
Q psy2989 2 AMALSDMFTLLFPAPWLFYMYTFGNHYKPLSPVAACYAWNIMNEVIPTLFHTASIWLTLALAVQR 66 (66)
Q Consensus 2 ~mAvaDllvml~y~P~~~y~y~~~~~~~~~~p~~~~y~~~~~h~~~~~~~HTiSiwLTv~LAv~R 66 (66)
+||+||+++++. +|....... .+.. .....|.... .+...+-..|++..+.+|+-|
T Consensus 52 nLAvaDll~~l~-~p~~~~~~~-~~~~---~~~~~c~~~~----~~~~~~~~~s~~~l~~isidR 107 (296)
T 2lnl_A 52 NLALADLLFALT-LPIWAASKV-NGWI---FGTFLCKVVS----LLKEVNFYSGILLLACISVDR 107 (296)
T ss_dssp HHHHHHHHHHHH-HHHHHHHHH-SSSC---CSSHHHHHHH----HHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHh-hhHHHhhcc-CCCc---cchhHHHHHh----hhhhhhHHHHHHHHHHHHhhh
Confidence 699999999875 565555444 2211 2234454443 334455567788777777755
Done!